Trial Profile
Pilot study of the effectiveness of the anaplerotic medication Triheptanoin in improving muscle strength in patients with sporadic Inclusion Body Myositis
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 24 Jun 2016
Price :
$35
*
At a glance
- Drugs Triheptanoin (Primary)
- Indications Inclusion body myositis
- Focus Therapeutic Use
- Sponsors Ultragenyx Pharmaceutical
- 04 Mar 2014 New trial record